top of page

RESISTANT_TO_mGrC

Last Updated

Current

node_web_buttons_proteindomain copy 2.png
node_web_buttons_proteindomain copy 2.png

Description

Clinical or preclinical studies testing for the ability of a variant to induce resistance to a particular treatment in a specific disease context, where the background (without variant) is sensitive to the treatment. (Secondary resistance mutation; CIViC)

Properties

  • clin_sig - Clinical significance from CIViC. Download details.

  • disease - List of the disesase ontology names

  • disease_id - List of the numerical part of the disesase ontology ids

  • pubmed - List of references (pubmed ids)

  • sourceCIViC

  • tier - Evidence level: B (clinical), C (case study), and D (preclinical) CIViC

  • url - List of CIViC urls

  • variant - List of variants

Updates

V7        281 edges

V6        322 edges

V5        294 edges

V4        308 edges

V3        317 edges

V2        317 edges

303 Twin Dolphin Drive, 6th Floor

Redwood City, California, USA, 94065

+1 (415) 570-4447

©2025 Mate Bioservices Inc.

Follow Us On:

  • LinkedIn
  • Twitter

User Login:

bottom of page